Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Completed × Neovascularization, Pathologic × S 3304 × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Neovascularization, Pathologic 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

S 3304 2 Zoledronic Acid 1 Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00078390 2018-05-02

Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer

Shionogi Inc.

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neovascularization, Pathologic

NCT00033215 2018-04-26

A Phase 1 Study of S-3304 in Patients With Solid Tumors

Shionogi Inc.

Phase 1 Completed

Neovascularization, Pathologic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡